Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
KEYNOTE-671: Randomized, double-blind, phase 3 study of pembrolizumab or placebo plus platinum-based chemotherapy followed by resection and pembrolizumab or placebo for early stage NSCLC.
- Authors
- Wakelee, HA[Wakelee, Heather A.]; Liberman, M[Liberman, Moishe]; Kato, T[Kato, Terufumi]; Tsuboi, M[Tsuboi, Masahiro]; Lee, SH[Lee, Se-Hoon]; He, J[He, Jie]; Gao, SG[Gao, Shugeng]; Chen, KN[Chen, Ke-Neng]; Dooms, CA[Dooms, Christophe Alfons]; Majem, M[Majem, Margarita]; Eigendorff, E[Eigendorff, Ekkehard]; Martinengo, GL[Martinengo, Gaston Lucas]; Bylicki, O[Bylicki, Olivier]; Rodriguez-Abreu, D[Rodriguez-Abreu, Delvys]; Chaft, JE[Chaft, Jamie E.]; Novello, S[Novello, Silvia]; Yang, J[Yang, Jing]; Keller, SM[Keller, Steven M.]; Samkari, A[Samkari, Ayman]; Spicer, J[Spicer, Jonathan]
- Issue Date
- 10-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.17
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 17
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.